Pfizer reported up to 12.3% placebo-adjusted weight loss at 28 weeks in a phase 2b trial of PF-08653944 (formerly MET-097i),…
Browsing: Clinical Updates
INTRODUCTION: The study aimed to develop consensus recommendations for the safe and appropriate use of liquid nitrogen spray cryotherapy in…
The U.S. FDA has granted Fast Track designation to pelareorep, an investigational immunotherapy from Oncolytics Biotech, in combination with bevacizumab…
Despite advances in outpatient therapies, hospitalization for adults with inflammatory bowel disease (IBD) remains common—and outcomes vary widely across institutions.…
The largest published study of molecular residual disease (MRD) in stage III colon cancer shows that Guardant Health’s ctDNA blood…
New research highlighted by HCPLive suggests that exhaled breath could become a noninvasive, real-time readout of gut microbiome activity, opening…
The Colorectal Cancer Alliance has launched CLEAR for CRC, a patient-centered initiative designed to close persistent gaps in early biomarker…
GRAIL has submitted the final module of its FDA Premarket Approval (PMA) application for the Galleri® multi-cancer early detection (MCED)…
A prospective multicenter study published in Therapeutic Advances in Gastrointestinal Endoscopy evaluated whether colon capsule endoscopy (CCE) could serve as…
Olympus Corporation of the Americas has announced the U.S. launch of SecureFlex™, its newest single-use fine needle biopsy (FNB) device…